Polyphosphate: A link between platelets, coagulation and inflammation

International Journal of Hematology

Volumn 95, Issue 4, 2012, Pages 346-352

  Morrissey, James H ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Blood clotting; Hemostasis; Inflammation; Platelets; Polyphosphate; Thrombosis

Indexed keywords

BACTERIAL PROTEIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 5; BRADYKININ; CALCIUM; FIBRINOGEN; KININOGEN; MAGNESIUM; POLYPHOSPHATE; PREKALLIKREIN; PROTHROMBIN; THROMBIN; ZINC;

ANGIOGENESIS; ANTICOAGULATION; APOPTOSIS; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; CELL PROLIFERATION; CELLULAR STRESS RESPONSE; FIBRIN POLYMERIZATION; HEMOSTASIS; HUMAN; INFLAMMATION; MOLECULAR DYNAMICS; NONHUMAN; OSTEOBLAST; POLYMERIZATION; SALMONELLA; THROMBOCYTE ACTIVATION; THROMBOGENESIS; THROMBOSIS;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; HUMANS; INFLAMMATION; PLATELET ACTIVATION; POLYPHOSPHATES; THROMBOSIS;

EID: 84862865744     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1054-5     Document Type: Article

References (53)

1. Brown MR, Kornberg A. Inorganic polyphosphate in the origin and survival of species. Proc Natl Acad Sci USA. 2004; 101:16085-7.
2. Ault-Riché D, Fraley CD, Tzeng CM, Kornberg A. Novel assay reveals multiple pathways regulating stress-induced accumulations of inorganic polyphosphate in Escherichia coli. J Bacteriol. 1998;180:1841-7.
3. Kornberg A, Rao NN, Ault-Riché D. Inorganic polyphosphate: a molecule of many functions. Annu Rev Biochem. 1999; 68:89-125.
4. Lorenz B, Schroder HC. Mammalian intestinal alkaline phosphatase acts as highly active exopolyphosphatase. Biochim Biophys Acta. 2001;1547:254-61.
5. Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA. 2006;103:903-8.
6. Lorenz B, Leuck J, Kohl D, Muller WE, Schroder HC. Anti-HIV-1 activity of inorganic polyphosphates. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:110-8.
7. Wang L, Fraley CD, Faridi J, Kornberg A, Roth RA. Inorganic polyphosphate stimulates mammalian TOR, a kinase involved in the proliferation of mammary cancer cells. Proc Natl Acad Sci USA. 2003;100:11249-54.
8. Han KY, Hong BS, Yoon YJ, Yoon CM, Kim YK, Kwon YG, et al. Polyphosphate blocks tumour metastasis via anti-angiogenic activity. Biochem J. 2007;406:49-55.
9. Hernandez-Ruiz L, Gonzalez-Garcia I, Castro C, Brieva JA, Ruiz FA. Inorganic polyphosphate and specific induction of apoptosis in human plasma cells. Haematologica. 2006;91:1180-6.
10. Kawazoe Y, Shiba T, Nakamura R, Mizuno A, Tsutsumi K, Uematsu T, et al. Induction of calcification in MC3T3-E1 cells by inorganic polyphosphate. J Dent Res. 2004;83:613-8.
11. Smith SA, Morrissey JH. Polyphosphate as a general procoagulant agent. J Thromb Haemost. 2008;6:1750-6.
12. Smith SA, Morrissey JH. Polyphosphate enhances fibrin clot structure. Blood. 2008;112:2810-6.
13. Müller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell. 2009;139:1143-56.
14. Mutch NJ, Myles T, Leung LL, Morrissey JH. Polyphosphate binds with high affinity to exosite II of thrombin. J Thromb Haemost. 2010;8:548-55.
15. Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, Rienstra CM, et al. Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood. 2010;116: 4353-9.
16. Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and 4. Blood. 2011;118:1952-61.
17. Choi SH, Smith SA, Morrissey JH. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood. 2011;118: 6963-70.
18. Mutch NJ, Engel R, Uitte de Willige S, Philippou H, Ariens RA. Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin. Blood. 2010;115:3980-8.
19. Docampo R, Moreno SN. Acidocalcisomes. Cell Calcium. 2011;50:113-9.
20. Ruiz FA, Lea CR, Oldfield E, Docampo R. Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem. 2004;279:44250-7.
21. Dean GE, Fishkes H, Nelson PJ, Rudnick G. The hydrogen ionpumping adenosine triphosphatase of platelet dense granule membrane. Differences from F1F0-and phosphoenzyme-type ATPases. J Biol Chem. 1984;259:9569-74.
22. White JG. The dense bodies of human platelets: inherent electron opacity of the serotonin storage particles. Blood. 1969;33: 598-606.
23. Fukami MH, Dangelmaier CA, Bauer JS, Holmsen H. Secretion, subcellular localization and metabolic status of inorganic pyrophosphate in human platelets. A major constituent of the aminestoring granules. Biochem J. 1980;192:99-105.
24. Brown MR, Kornberg A. The long and short of it-polyphosphate, PPK and bacterial survival. Trends Biochem Sci. 2008;33:284-90.
25. Morrissey JH. Tissue factor: a key molecule in hemostatic and nonhemostatic systems. Int J Hematol. 2004;79:103-8.
26. Colman RW, Schmaier AH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood. 1997;90:3819-43.
27. Gailani D, Renné T. Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol. 2007;27:2507-13.
28. Müller F, Renné T. Novel roles for factor XII-driven plasma contact activation system. Curr Opin Hematol. 2008;15:516-21.
29. Frick IM, Akesson P, Herwald H, Morgelin M, Malmsten M, Nagler DK, et al. The contact system-a novel branch of innate immunity generating antibacterial peptides. EMBO J. 2006;25:5569-78.
30. Ben Nasr A, Wistedt A, Ringdahl U, Sjobring U. Streptokinase activates plasminogen bound to human group C and G streptococci through M-like proteins. Eur J Biochem. 1994;222:267-76.
31. Ben Nasr A, Olsen A, Sjobring U, Muller-Esterl W, Bjorck L. Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli. Mol Microbiol. 1996;20:927-35.
32. Kalter ES, van Dijk WC, Timmerman A, Verhoef J, Bouma BN. Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus. J Infect Dis. 1983;148:682-91.
33. Loza JP, Gurewich V, Johnstone M, Pannell R. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis. Thromb Haemost. 1994;71:347-52.
34. Ghebrehiwet B, Randazzo BP, Dunn JT, Silverberg M, Kaplan AP. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest. 1983;71:1450-6.
35. Colman RW, Jameson BA, Lin Y, Johnson D, Mousa SA. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood. 2000;95:543-50.
36. Jacobsen S, Kriz M. Some data on two purified kininogens from human plasma. Br J Pharmacol Chemother. 1967;29:25-36.
37. Choi SH, Collins JN, Smith SA, Davis-Harrison RL, Rienstra CM, Morrissey JH. Phosphoramidate end labeling of inorganic polyphosphates: facile manipulation of polyphosphate for investigating and modulating its biological activities. Biochemistry. 2010;49:9935-41.
38. Lawson JH, Kalafatis M, Stram S, Mann KG. A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem. 1994;269:23357-66.
39. Orfeo T, Brufatto N, Nesheim ME, Xu H, Butenas S, Mann KG. The factor V activation paradox. J Biol Chem. 2004;279: 19580-91.
40. Broze GJ Jr. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagul Fibrinolysis. 1995; 6(SUPPL. 1):S7-13.
41. Mast AE, Broze GJ Jr. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Blood. 1996;87:1845-50.
42. Collen A, Smorenburg SM, Peters E, Lupu F, Koolwijk P, Van Noorden C, et al. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res. 2000;60:6196-200.
43. Parise P, Morini M, Agnelli G, Ascani A, Nenci GG. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis. Blood Coagul Fibrinolysis. 1993;4:721-7.
44. Nenci GG, Parise P, Morini M, Rossini A, Agnelli G. Fibrin clots obtained from plasma containing heparin show a higher sensitivity to t-PA-induced lysis. Blood Coagul Fibrinolysis. 1992;3:279-85.
45. Carr ME Jr, Cromartie R, Gabriel DA. Effect of homo poly(Lamino acids) on fibrin assembly: role of charge and molecular weight. Biochemistry. 1989;28:1384-8.
46. Walsh PN, Gailani D. Factor XI. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, editors. Hemostasis and thrombosis: basic principles and clinical practice. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 221-33.
47. Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem. 1991;266:7353-8.
48. Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science. 1991;253:909-12.
49. Gailani D, Broze GJ Jr. Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation. Blood. 1993;82:813-9.
50. Gailani D, Broze GJ Jr. Effects of glycosaminoglycans on factor XI activation by thrombin. Blood Coagul Fibrinolysis. 1993;4:15-20.
51. Pedicord DL, Seiffert D, Blat Y. Feedback activation of factor XI by thrombin does not occur in plasma. Proc Natl Acad Sci USA. 2007;104:12855-60.
52. Caen J, Wu Q. Hageman factor, platelets and polyphosphates: early history and recent connection. J Thromb Haemost. 2010;8:1670-4.
53. Ong SY, Wu J, Moochhala SM, Tan MH, Lu J. Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties. Biomaterials. 2008;29:4323-32.